FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
14/12/2024
Voltar para busca
Dado oficial do USPTO
DRUGOME
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
14/12/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 35, 36, 42
Data de depósito
19/08/2022
Data de registro
11/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/06/2024
Última transação
11/06/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
JP
Examinador
WUDARSKY, MINDY CHEK
Unidade examinadora
M80
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of adjoining incomplete polygons appearing as stylized molecules next to the word "DRUGOME" in stylized lettering.
Titulares e representantes
Titulares
Sumitomo Pharma Co., Ltd.
Representantes
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett &
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 36Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Calculating machinesdata processing equipmentcomputers; downloadable computer software for data aggregation automationdatabase creationdata analysisdata reporting and data visualization; downloadable computer software for providinganalyzing and generating reports; downloadable computer software for data processing; electronic apparatuselectronic equipmentdownloadable computer software and programs for the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and transmission of dataimages and information; electronic apparatuselectronic equipmentdownloadable computer software and programs for the conversionanalysisprocessingstorage and transmission of artificial intelligence; downloadable computer software for database integration; downloadable computer software for creating searchable databases of information and data; downloadable software for analytics in the fields of healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentfor clinical trial and post-market trial data; downloadable computer software featuring electronic computer databases of pharmaceuticalsbiomedical research in support of data analysis and for clinical trial and post-market trial data; downloadable computer search engine software for compilingaccessing and providing updated scientificmedicalpharmaceutical and clinical informationnews information of general interest
Classe 35
Advertising services; business management; business administration; providing office functions; business research services; business information services; market research; provision of market research information; data processing services; analysis of business data; statistical analysis and reporting services using artificial intelligence and machine learning for business purposes in the pharmaceutical and biomedical fields; business analysis and statistical analysis of healthcare datapharmaceuticalsbiomedical researchfor clinical trial and post-market dataall the foregoing for business purposes; systematization of data in computer databases; compilation of data for business analysis purposescompilation of information into computer databases for business data analysis purposes in the fields of healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentclinical trials and post-market data; professional business data analysis and consultancy and statistical analysis for business purposes in the fields of healthcarepharmaceuticalsbiomedicineclinical trialsepidemiological researchpharmacoepidemiological researchpost-market trials and research evaluating epidemiological outcomes
Classe 36
Financial analysis; financial consulting; financial valuations and forecasting; financial analysis of statistics and data; financial analysis of investments in pharmaceutical and biomedical research and developmentclinical and post-market trials; financial evaluationtrackinganalysisforecastingconsultancyadvisory and research services relating to healthcarepharmaceuticalsbiomedicinepharmaceutical and biomedical research and developmentclinical and post-market trials
Classe 42
Scientific and technological servicesdata aggregation automationdatabase creationdata analysisdata reporting and data visualization in the field of healthcarepharmaceuticalsbiomedical researchfor clinical trial and post-marketing and research and design relating thereto; analysis of technical data by computersdata automation and collection service using proprietary software to evaluateanalyze and collect dataproviding use of online non-downloadable software for analyzing data; pharmaceuticalbiomedicalbiological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biopharmaceutical research and development; providing scientific research information in the field of pharmaceuticalsbiomedicineclinical trials and post-market trials; cloud computing featuring software for use in data aggregation automationdatabase creationdata analysisdata reporting and data visualization; providing temporary use of online non-downloadable computer software featuring electronic computer databases of pharmaceuticalsbiomedicinepharmaceutical and biopharmaceutical research and developmentmedical informationclinical trial and post-market trial data for data analysisdata reporting and data visualization; providing temporary use of online non-downloadable computer software for research in the field of pharmaceuticals and biopharmaceuticals; providing temporary use of online non-downloadable computer software for compilingaccessingcontrollingmanaging and providing updated scientificpharmaceuticalmedical and clinical informationnews information of general interest; providing temporary use of non-downloadable software applications accessible via a web site for data analyticsfinancial analytics and risk management for use in the fields of pharmaceutical and biomedical research and developmentclinical trialsthe provision of medical and healthcare services
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/11/2024
FIMP
FINAL DISPOSITION PROCESSED
21/11/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/09/2024
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
03/09/2024
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
16/06/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/06/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/03/2024
PUBO
PUBLISHED FOR OPPOSITION
26/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/02/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
17/02/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/02/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
17/02/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
17/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/01/2024
RFNT
REFUSAL PROCESSED BY IB
15/08/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/07/2023
RFRR
REFUSAL PROCESSED BY MPU
21/07/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/06/2023
CNRT
NON-FINAL ACTION WRITTEN
14/06/2023
DOCK
ASSIGNED TO EXAMINER
07/06/2023
MAFR
APPLICATION FILING RECEIPT MAILED
13/01/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/01/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/01/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DRUGOME ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.